CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor
NCT03182816
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
BIOLOGICAL:
anti-CTLA-4/PD-1 expressing EGFR-CAR-T
Sponsor
Shanghai Cell Therapy Research Institute